You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 12, December 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE ANNUAL MEETING OF THE SOCIETY OF SURGICAL ONCOLOGY, LONDON, APRIL 27 TO APRIL 30, 1987-PART II
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Natural Killer Activity of Lymphocytes Infiltrating Human Lung Cancers Following Preoperative Systemic Recombinant Interleukin 2

Timothy M. Anderson, MD; Yukihiro Ibayashi, MD; Yutaka Tokuda, MD; Steve Colquhoun, MD; Carmack Holmes, MD; Sidney H. Golub, PhD

Arch Surg. 1987;122(12):1446-1450.


Abstract

• Tumor-infiltrating lymphocytes (TILs) show depressed natural killer (NK) activity compared with peripheral blood lymphocytes (PBLs). To determine if TIL NK function can be reactivated in vivo, 11 patients with tumors metastatic to the lung were treated with systemic recombinant interleukin 2 (rlL-2). Spontaneous TIL NK activity and NK activity after three days' incubation with 100 U/mL of rlL-2 were increased in patients receiving 15000 U/kg of rlL-2 preoperatively compared with those receiving between 1000 and 10000 U/kg. Histologically, higher doses of rlL-2 increased the number of intratumoral lymphocytes, the level of peritumoral lymphocytic transferrin, and the expression of HLA-DR. Spontaneous PBL NK activity in patients receiving between 10000 and 15000 U/kg of rlL-2 was also increased and was further increased by in vitro culture with rlL-2. Thus, PBL NK activity and TIL NK function in vivo can be augmented with 15000 U/kg of systemic rlL-2. Both TIL- and PBL-inducible cytotoxicities were further enhanced by in vitro culture with rlL-2.

(Arch Surg 1987;122:1446-1450)



Author Affiliations

From the Division of Surgical Oncology, UCLA School of Medicine; and the John Wayne Cancer Clinic and Jonsson Comprehensive Cancer Center, Los Angeles.


Footnotes

Accepted for publication July 14, 1987.

Read before the Annual Meeting of the Society of Surgical Oncology, London, April 30, 1987.

Reprint requests to Division of Surgical Oncology, 9-267 Louis Factor Building, UCLA School of Medicine, Los Angeles, CA 90024 (Dr Holmes).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.